Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Cash Flow Statement
Cash Flow Statement
Biohaven Pharmaceutical Holding Company Ltd
Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|
Operating Cash Flow | ||||||
Net Income |
(570)
|
(544)
|
(431)
|
(465)
|
(408)
|
|
Depreciation & Amortization |
1
|
3
|
4
|
5
|
7
|
|
Stock-Based Compensation |
194
|
157
|
141
|
129
|
0
|
|
Other Non-Cash Items |
300
|
260
|
148
|
135
|
45
|
|
Cash Taxes Paid |
38
|
0
|
0
|
0
|
(33)
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
(29)
|
(36)
|
(15)
|
32
|
25
|
|
Cash from Operating Activities |
(298)
N/A
|
(316)
-6%
|
(293)
+7%
|
(292)
+0%
|
(332)
-14%
|
|
Investing Cash Flow | ||||||
Capital Expenditures |
(6)
|
(7)
|
(6)
|
(3)
|
(3)
|
|
Other Items |
(299)
|
(299)
|
(187)
|
(127)
|
133
|
|
Cash from Investing Activities |
(305)
N/A
|
(306)
0%
|
(193)
+37%
|
(130)
+33%
|
130
N/A
|
|
Financing Cash Flow | ||||||
Net Issuance of Common Stock |
284
|
0
|
0
|
0
|
243
|
|
Other |
484
|
487
|
380
|
213
|
(31)
|
|
Cash from Financing Activities |
768
N/A
|
771
+0%
|
664
-14%
|
497
-25%
|
212
-57%
|
|
Change in Cash | ||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(0)
|
|
Net Change in Cash |
166
N/A
|
150
-10%
|
178
+19%
|
75
-58%
|
10
-87%
|
|
Free Cash Flow | ||||||
Free Cash Flow |
(304)
N/A
|
(323)
-6%
|
(299)
+7%
|
(295)
+1%
|
(335)
-13%
|